Euro-Med Laboratories Phil., Inc. (PSE:EURO)

PSE:EURO Balance Sheet

Financials in millions PHP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	992.93	857.62	881.35	615.72	554.5	508.42
Trading Asset Securities	233.56	233.56	202.01	190.6	173.39	224.03
Cash & Short-Term Investments	1,226	1,091	1,083	806.31	727.89	732.44
Cash Growth	1.96%	0.72%	34.36%	10.77%	-0.62%	-45.66%
Accounts Receivable	2,020	1,807	1,592	1,439	1,319	1,537
Other Receivables	-	132.2	111.52	43.87	44.07	38.84
Receivables	2,020	1,940	1,703	1,483	1,363	1,584
Inventory	1,705	1,742	1,693	1,537	1,264	1,396
Prepaid Expenses	-	330.91	321.84	317.88	296.64	335.8
Other Current Assets	322.54	214.64	334.27	283.44	259.4	263.87
Total Current Assets	5,274	5,318	5,135	4,428	3,911	4,312
Property, Plant & Equipment	4,887	4,933	4,961	4,961	5,052	4,986
Long-Term Investments	-	0.2	0.2	0.2	0.2	0.2
Other Intangible Assets	268.13	268.13	268.13	268.13	268.21	268.39
Long-Term Deferred Tax Assets	121.36	122.26	109.15	97.15	105.95	125.32
Long-Term Deferred Charges	-	12.65	21.07	38.79	51.44	84.36
Other Long-Term Assets	338.93	295.41	268.76	266.17	302.82	295.49
Total Assets	10,889	10,950	10,764	10,059	9,691	10,072
Accounts Payable	376.14	349.49	477.38	345.59	301.14	529.84
Accrued Expenses	-	139.51	104.6	69.31	85.39	192.46
Short-Term Debt	3,045	3,040	3,014	2,633	2,283	2,642
Current Portion of Long-Term Debt	197.81	285.65	209.75	184.3	195.08	353.63
Current Portion of Leases	66.26	66.98	58.6	60.82	49.18	37.78
Current Income Taxes Payable	21.44	26.61	51.64	31.18	22.8	56.98
Current Unearned Revenue	-	0.37	1.81	0.75	0.4	0.39
Other Current Liabilities	-0	0.22	0.11	0.62	0.6	20.11
Total Current Liabilities	3,707	3,909	3,918	3,326	2,937	3,833
Long-Term Debt	768.23	774.25	666.91	663.62	788.75	459.89
Long-Term Leases	114	125.53	89.48	138.91	105.29	97.87
Total Liabilities	4,847	5,067	4,919	4,350	4,051	4,624
Common Stock	4,112	4,112	4,112	4,112	4,112	4,112
Additional Paid-In Capital	66.61	66.61	66.61	66.61	66.61	66.61
Retained Earnings	1,884	1,724	1,692	1,547	1,494	1,325
Comprehensive Income & Other	-19.77	-19.77	-25.15	-16.52	-31.79	-55.6
Shareholders' Equity	6,042	5,883	5,845	5,709	5,641	5,448
Total Liabilities & Equity	10,889	10,950	10,764	10,059	9,691	10,072
Total Debt	4,191	4,293	4,039	3,681	3,421	3,591
Net Cash (Debt)	-2,965	-3,202	-2,956	-2,874	-2,693	-2,859
Net Cash Per Share	-0.70	-0.78	-0.72	-0.70	-0.65	-0.70
Filing Date Shares Outstanding	4,678	4,112	4,112	4,112	4,112	4,112
Total Common Shares Outstanding	4,678	4,112	4,112	4,112	4,112	4,112
Working Capital	1,567	1,409	1,217	1,102	973.51	478.59
Book Value Per Share	1.29	1.43	1.42	1.39	1.37	1.32
Tangible Book Value	5,774	5,615	5,577	5,441	5,372	5,179
Tangible Book Value Per Share	1.23	1.37	1.36	1.32	1.31	1.26
Land	-	166.77	173.34	131.83	106.59	106.59
Buildings	-	3,043	2,981	2,816	2,777	2,552
Machinery	-	6,499	6,365	6,278	6,254	6,193

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.